News | Mammography | March 09, 2017

Solis Mammography Supports Texas Tomosynthesis Insurance Coverage Bill

HB1036 requires commercial providers to cover 3-D mammography

Solis Mammography, Texas, HB 1036, insurance coverage, 3-D mammography, tomosynthesis

March 9, 2017 — Solis Mammography, an independent provider of breast imaging services, believes that an educated patient makes the best decisions about their health. For this reason, Solis is urging support for Texas House Bill 1036 (HB1036), which if passed, would require all commercial insurance providers in Texas to cover digital breast tomosynthesis, also known as 3-D mammography, for breast cancer screening and diagnosis. House Bill 1036 was introduced on Jan. 1 by Texas Rep. Senfronia Thompson (D-Houston).

In November 2014, the American College of Radiology released this position statement on 3-D mammography: “To be clear; tomosynthesis (3-D) is no longer investigational. It has been shown to improve key screening parameters compared to (2-D) digital mammography. The college applauds the decision by the Centers for Medicare and Medicaid Services (CMS) to facilitate access to these exams by covering beneficiaries for tomosynthesis and urges private payers to do the same.”

In 2016, Blue Cross Blue Shield began its 3-D mammography coverage in Texas, and Cigna announced on Aug. 23, 2016, that they would begin providing coverage, becoming the first national private insurer to cover 3-D mammograms. United Healthcare recently announced a similar decision, adding 3-D mammography to its list of covered services for screening and diagnostic mammography effective Apr. 1.

The movement has shifted to other state legislatures who have already passed similar legislation to HB1036.  These states include Connecticut, Pennsylvania, Illinois and most recently New York. 

Research has proven the effectiveness of 3-D mammography, demonstrating increases in early detection of breast cancer by 54 percent and decreases in recall rates by 37 percent, as published in the American Journal of Roentgenology. Early detection contributes to long-term survival and also to quality of life, as masses found earlier will likely result in less aggressive treatment.

“In 2010, Solis Mammography’s chief medical officer, Dr. Steven Rose, presented the very first patient in the country to be diagnosed with 3-D alone to a [U.S.] Food and Drug Administration panel,” said James Polfreman, CEO of Solis Mammography. “In 2011, the FDA approved 3-D mammography, and in 2015, Medicare announced its decision to cover 3-D. It’s been another full two years since Medicare’s decision and we are still seeing too many women who have health insurance, but can’t get the best screening technology available because of a lack of coverage. This is simply not acceptable and women deserve better.”

For women whose insurance does not cover the cost of 3-D, out-of-pocket expenses can range from $50 to $150 for the added benefits and specificity of 3-D mammography.  These benefits include:

  • It provides around 60 layers of images, allowing radiologists to see cancers as early as stage zero;
  • It is better able to see behind dense breast tissue, which is important for breast cancer detection as not all breast cancers cause a lump in the breast that can be felt; and
  • It enhances the accuracy of breast cancer screenings by increasing specificity of early detection, reducing unnecessary callbacks (aka false positives) and reducing the need for unnecessary biopsies and other follow-up testing.

For more information: www.solismammo.com

Related Content

Siemens Healthineers Introduces Mammomat Revelation Mammography System for Improved Biopsy Workflow
Technology | Mammography | December 11, 2017
Siemens Healthineers unveiled the new Mammomat Revelation premium mammography platform at the 2017 Radiological Society...
Breast Cancer Screening Performance Impacted by Mean Mammographic Compression Pressure
News | Mammography | December 08, 2017
Dutch researchers demonstrated a strong relationship between compression pressure in mammography and breast cancer...
Sponsored Content | Videos | Mammography | December 06, 2017
Martin Yaffe, Ph.D., FAAPM, senior scientist, physical sciences/imaging research, Sunnybrook Health Sciences Centre,
Ikonopedia and Konica Minolta Showcase Integrated Breast Imaging Workflow and Reporting at RSNA
News | Breast Imaging | December 05, 2017
Ikonopedia and Konica Minolta Healthcare Americas Inc. showcased integrated breast imaging workflow and reporting at...
Sponsored Content | Videos | Breast Imaging | December 05, 2017
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, attending radiologis
Numerous Studies Highlight Importance of Quantitative Breast Imaging Analysis at RSNA 2017
News | Breast Density | November 30, 2017
The importance of quantitative analysis in breast imaging was the focus of numerous abstracts accepted for presentation...
Hologic Receives FDA 510(k) Clearance of Quantra 2.2 Breast Density Assessment Software
Technology | Breast Density | November 28, 2017
Hologic Inc. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its...
Eizo RadiForce RX560 Monitor Receives FDA 510(k) for Tomosynthesis and Digital Mammography
Technology | November 20, 2017
Eizo Corp. announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for breast tomosynthesis...
Biop Medical Launches Cervical Cancer Diagnosis Technology at MEDICA 2017

Biop Medical cervical cancer detection system

Technology | Women's Health | November 13, 2017
November 13, 2017 — Biop Medical announced it will present its point-of-care...
Overlay Init